The transcription factor activating enhancer-binding protein epsilon (AP-2ε) regulates the core promoter of type II collagen (COL2A1)

FEBS Journal

Volumn 280, Issue 6, 2013, Pages 1397-1408

  Niebler, Stephan ^a   Bosserhoff, Anja K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

AP 2 ; cartilage; chondrocytes; COL2A1; transcriptional regulation

Indexed keywords

COLLAGEN TYPE 2; COLLAGEN TYPE 2A1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2 EPSILON; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CELL STRAIN; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; COL2A1 GENE; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; BONE NEOPLASMS; CARTILAGE; CELL LINE, TUMOR; CHONDROBLASTOMA; CHONDROCYTES; CHROMATIN IMMUNOPRECIPITATION; COLLAGEN TYPE II; COMPUTATIONAL BIOLOGY; CONSENSUS SEQUENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; HYPERTROPHY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEOTIDE MOTIFS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION, GENETIC;

EID: 84875369275     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12130     Document Type: Article

References (32)

1. Lefebvre V, &, Smits P, (2005) Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75, 200-212.
2. Shoulders MD, &, Raines RT, (2009) Collagen structure and stability. Annu Rev Biochem 78, 929-958.
3. Renard E, Poree B, Chadjichristos C, Kypriotou M, Maneix L, Bigot N, Legendre F, Ollitrault D, de Crombrugghe B, Mallein-Gerin F, et al,. (2012) Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med (Berl) 90, 649-666.
4. Vikkula M, Metsaranta M, &, Ala-Kokko L, (1994) Type II collagen mutations in rare and common cartilage diseases. Ann Med 26, 107-114.
5. Goldring MB, (2000) The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43, 1916-1926.
6. Kypriotou M, Fossard-Demoor M, Chadjichristos C, Ghayor C, de Crombrugghe B, Pujol JP, &, Galera P, (2003) SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell Biol 22, 119-129.
7. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ, &, Goldring MB, (2003) Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 278, 17688-17700.
8. Jash A, Yun K, Sahoo A, So JS, &, Im SH, (2012) Looping mediated interaction between the promoter and 3′ UTR regulates type II collagen expression in chondrocytes. PLoS One 7, e40828.
9. Karsenty G, &, Wagner EF, (2002) Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2, 389-406.
10. Goldring MB, Tsuchimochi K, &, Ijiri K, (2006) The control of chondrogenesis. J Cell Biochem 97, 33-44.
11. Hojo H, Ohba S, Yano F, &, Chung UI, (2010) Coordination of chondrogenesis and osteogenesis by hypertrophic chondrocytes in endochondral bone development. J Bone Miner Metab 28, 489-502.
12. Hartmann C, (2009) Transcriptional networks controlling skeletal development. Curr Opin Genet Dev 19, 437-443.
13. Goldring MB, &, Goldring SR, (2007) Osteoarthritis. J Cell Physiol 213, 626-634.
14. van der Kraan PM, &, van den Berg WB, (2012) Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 20, 223-232.
15. Eckert D, Buhl S, Weber S, Jager R, &, Schorle H, (2005) The AP-2 family of transcription factors. Genome Biol 6, 246.
16. Hilger-Eversheim K, Moser M, Schorle H, &, Buettner R, (2000) Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260, 1-12.
17. Huang Z, Xu H, &, Sandell L, (2004) Negative regulation of chondrocyte differentiation by transcription factor AP-2alpha. J Bone Miner Res 19, 245-255.
18. Rock JR, Lopez MC, Baker HV, &, Harfe BD, (2007) Identification of genes expressed in the mouse limb using a novel ZPA microarray approach. Gene Expr Patterns 8, 19-26.
19. Feng W, &, Williams T, (2003) Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb. Mol Cell Neurosci 24, 460-475.
20. Wang HV, Vaupel K, Buettner R, Bosserhoff AK, &, Moser M, (2004) Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon. Dev Dyn 231, 128-135.
21. Tummala R, Romano RA, Fuchs E, &, Sinha S, (2003) Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family. Gene 321, 93-102.
22. Wenke AK, Rothhammer T, Moser M, &, Bosserhoff AK, (2006) Regulation of integrin alpha10 expression in chondrocytes by the transcription factors AP-2epsilon and Ets-1. Biochem Biophys Res Commun 345, 495-501.
23. Wenke AK, Grassel S, Moser M, &, Bosserhoff AK, (2009) The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes. FEBS J 276, 2494-2504.
24. Wenke AK, Niebler S, Grassel S, &, Bosserhoff AK, (2011) The transcription factor AP-2varepsilon regulates CXCL1 during cartilage development and in osteoarthritis. Osteoarthritis Cartilage 19, 206-212.
25. Feng W, Simoes-de-Souza F, Finger TE, Restrepo D, &, Williams T, (2009) Disorganized olfactory bulb lamination in mice deficient for transcription factor AP-2epsilon. Mol Cell Neurosci 42, 161-171.
26. Buettner R, Kannan P, Imhof A, Bauer R, Yim SO, Glockshuber R, Van Dyke MW, &, Tainsky MA, (1993) An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol 13, 4174-4185.
27. Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, &, Bar-Eli M, (2001) Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo. Oncogene 20, 3363-3375.
28. Ghayor C, Chadjichristos C, Herrouin JF, Ala-Kokko L, Suske G, Pujol JP, &, Galera P, (2001) Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. J Biol Chem 276, 36881-36895.
29. Chadjichristos C, Ghayor C, Kypriotou M, Martin G, Renard E, Ala-Kokko L, Suske G, de Crombrugghe B, Pujol JP, &, Galera P, (2003) Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes. J Biol Chem 278, 39762-39772.
30. Savagner P, Miyashita T, &, Yamada Y, (1990) Two silencers regulate the tissue-specific expression of the collagen II gene. J Biol Chem 265, 6669-6674.
31. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, Arbiser JL, &, Apperley JF, (1994) Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest 94, 2307-2316.
32. Dignam JD, Martin PL, Shastry BS, &, Roeder RG, (1983) Eukaryotic gene transcription with purified components. Methods Enzymol 101, 582-598.